SCHEMBL24494597

SCHEMBL24494597

BrCc1ccc2nccn2c1

nearest known ligand 0.68

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.68
▸ DYRK1A Q13627 2/20 0.49
▸ MEN1 O00255 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ DAO P14920 1/20 0.44
▸ MERTK Q12866 6/20 0.43
▸ CPB2 Q96IY4 1/20 0.43
▸ RET P07949 1/20 0.42
▸ AXL P30530 5/20 0.41
▸ FLT3 P36888 5/20 0.41
▸ NAMPT P43490 4/20 0.40
▸ MET P08581 2/20 0.39
▸ PIK3CG P48736 1/20 0.38
▸ TYRO3 Q06418 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6092812 0.81 KEAP1 (1.00) KEAP1DYRK1AMEN1CYP1A2KMT2A
SCHEMBL74518 0.81 KEAP1 (0.68) KEAP1DYRK1AMEN1CYP1A2KMT2A
SCHEMBL2049672 0.81 KEAP1 (0.68) KEAP1DYRK1AMEN1CYP1A2KMT2A
SCHEMBL14638413 0.81 KEAP1 (0.68) KEAP1DYRK1AMEN1CYP1A2KMT2A
SCHEMBL2535366 0.81 KEAP1 (0.68) KEAP1DYRK1AMEN1CYP1A2KMT2A
SCHEMBL14554770 0.81 KEAP1 (0.68) KEAP1DYRK1AMEN1CYP1A2KMT2A
Ammonia Solution, Strong SCHEMBL28922912 0.79 KEAP1 (0.66) KEAP1DYRK1AMEN1CYP1A2KMT2A
Hydrochloric Acid SCHEMBL23201169 0.79 KEAP1 (0.96) KEAP1DYRK1AMEN1CYP1A2KMT2A
Hydrochloric Acid SCHEMBL17184538 0.79 KEAP1 (0.96) KEAP1DYRK1AMEN1CYP1A2KMT2A
Hydrochloric Acid SCHEMBL8830070 0.79 KEAP1 (0.66) KEAP1DYRK1AMEN1CYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022116998-A1 FUSED HETEROCYCLIC DERIVATIVES AS HBV INHIBITORS Janssen Sciences Ireland Unlimited Company (IE) 2022-06-09 — — WO disclosed
WO-2022116998-A1 FUSED HETEROCYCLIC DERIVATIVES AS HBV INHIBITORS Janssen Sciences Ireland Unlimited Company (IE) 2022-06-09 — — WO disclosed
Send feedback